GS
WGSWW

GTS Securities’s GeneDx Holdings Warrant WGSWW Stock Holding History

GTS Securities’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-56,624
Closed -$4.19K – 4138
2024
Q3 		$4.19K Buy
56,624
+34,193
+152% +$1.18K ﹤0.01% 3999
2024
Q2 		$673 Buy
+22,431
New +$765 ﹤0.01% 3857

Other funds holding WGSWW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

GTS Securities's WGSWW Position: Q4 2024 in Review

GTS Securities sold out of GeneDx Holdings Warrant (WGSWW) in Q4 2024, closing a stake of 56,624 shares — an estimated $4.19K sold.

GTS Securities first reported a position in WGSWW in Q2 2024 and held it in 2 quarters. The position peaked at $4.19K in Q3 2024. 17 funds tracked by Wall St. Rank hold WGSWW as of Q4 2024.

  • GTS Securities reported no remaining GeneDx Holdings Warrant position as of Q4 2024 after selling out during the quarter.
  • GTS Securities sold 56,624 GeneDx Holdings Warrant shares in Q4 2024, an estimated $4.19K.
  • GTS Securities first reported a position in GeneDx Holdings Warrant in Q2 2024 and held it in 2 quarters.
  • GTS Securities's GeneDx Holdings Warrant position peaked at $4.19K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q4 2024.

Based on GTS Securities's 13F filing for Q4 2024, filed 18 Feb 2025.